Rising Star Awards | Read Press Release

ABRAHAM GITTERMAN focuses on FDA and healthcare regulatory, compliance, and fraud and abuse matters involving pharmaceutical and medical device manufacturers. He regularly counsels clients on FDA-regulated advertising and promotion, scientific exchange and compliant medical affairs activities, FDAMA 114 and health care economic information, digital health, social media, continuing medical education, interactions with healthcare professionals, product development and lifecycle management, and the Drug Supply Chain Security Act.  Mr. Gitterman also assists with the creation, design, implementation and review of corporate compliance programs, both generally and pursuant to Corporate Integrity Agreements with OIG.  Mr. Gitterman works closely with drug and device manufacturers regarding market access and patient support programs pre- and post-approval including reimbursement support, field reimbursement managers, and patient financial assistance programs.  Mr. Gitterman also has extensive experience counseling clients on the Physician Payments Sunshine Act and related state transparency and “gift ban” laws.  Throughout his career, Mr. Gitterman has been seconded to numerous life sciences companies and served on many promotional and medical review committees, allowing him to specialize in the FDA regulatory and healthcare compliance needs of commercial and medical teams.